162 related articles for article (PubMed ID: 10552028)
1. MRI of growth hormone-secreting pituitary adenomas: factors determining pretreatment hormone levels.
Saeki N; Iuchi T; Isono S; Eda M; Yamaura A
Neuroradiology; 1999 Oct; 41(10):765-71. PubMed ID: 10552028
[TBL] [Abstract][Full Text] [Related]
2. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
Anik I; Cabuk B; Gokbel A; Selek A; Cetinarslan B; Anik Y; Ceylan S
World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of cavernous sinus involvement by pituitary adenomas.
Scotti G; Yu CY; Dillon WP; Norman D; Colombo N; Newton TH; De Groot J; Wilson CB
AJR Am J Roentgenol; 1988 Oct; 151(4):799-806. PubMed ID: 3262283
[TBL] [Abstract][Full Text] [Related]
5. Acromegaly in a patient with normal pituitary gland and somatotropic adenoma located in the sphenoid sinus.
Kurowska M; Tarach JS; Zgliczyński W; Malicka J; Zieliński G; Janczarek M
Endokrynol Pol; 2008; 59(4):348-51. PubMed ID: 18777506
[TBL] [Abstract][Full Text] [Related]
6. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M; Motiei-Langroudi R
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[TBL] [Abstract][Full Text] [Related]
7. MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case.
Curto L; Squadrito S; Almoto B; Longo M; Granata F; Salpietro F; Torre ML; Marini F; Trimarchi F; Cannavo S
Pituitary; 2007; 10(3):299-305. PubMed ID: 17334927
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of cavernous sinus invasion by pituitary adenoma diagnostic criteria and surgical findings.
Vieira JO; Cukiert A; Liberman B
Arq Neuropsiquiatr; 2004 Jun; 62(2B):437-43. PubMed ID: 15273840
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
11. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage.
Lucas T; Astorga R; Catalá M;
Clin Endocrinol (Oxf); 2003 Apr; 58(4):471-81. PubMed ID: 12641631
[TBL] [Abstract][Full Text] [Related]
12. MRI of pituitary adenomas in acromegaly.
Marro B; Zouaoui A; Sahel M; Crozat N; Gerber S; Sourour N; Sag K; Marsault C
Neuroradiology; 1997 Jun; 39(6):394-9. PubMed ID: 9225316
[TBL] [Abstract][Full Text] [Related]
13. Fusiform dilatation of the cavernous carotid artery in acromegalic patients.
Sivakumar W; Chamoun RB; Riva-Cambrin J; Salzman KL; Couldwell WT
Acta Neurochir (Wien); 2013 Jun; 155(6):1077-83; discussion 1083. PubMed ID: 23588275
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion.
Park HH; Kim EH; Ku CR; Lee EJ; Kim SH
World Neurosurg; 2018 Sep; 117():e280-e289. PubMed ID: 29906579
[TBL] [Abstract][Full Text] [Related]
15. Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas.
Iuchi T; Saeki N; Osato K; Yamaura A
Acta Neurochir (Wien); 2000; 142(12):1345-51. PubMed ID: 11214627
[TBL] [Abstract][Full Text] [Related]
16. [Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences].
Zieliński G; Podgórski JK; Koziarski A; Potakiewicz Z; Warczyńska A; Zgliczyński W; Makowska A
Przegl Lek; 2004; 61(9):928-34. PubMed ID: 15803901
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
18. [MRI diagnosis of cavernous sinus invasion by pituitary adenomas].
Cottier JP; Destrieux C; Vinikoff-Sonier C; Jan M; Herbreteau D
Ann Endocrinol (Paris); 2000 Sep; 61(3):269-74. PubMed ID: 10970953
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings.
Vieira JO; Cukiert A; Liberman B
Surg Neurol; 2006 Feb; 65(2):130-5; discussion 135. PubMed ID: 16427401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
